Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/41334
Type
ArticleCopyright
Restricted access
Embargo date
2022-12-31
Collections
Metadata
Show full item record
COUNTRY PROfiLE: LEPROSY IN BRAZIL
Health surveillance
Disease prevention
Communicable disease control
Leprosy
Communicable disease
Drug therapy
Vigilância em Saúde Pública
Prevenção de Doenças
Controle de Doenças Transmissíveis
Communicable Disease
Tratamento Farmacológico
Affilliation
Universidade Federal Fluminense. Departamento de Epidemiologia e Bioestatística. Niterói, RJ, Brasil.
Governo Estadual de Minas Gerais. Secretaria Estadual de Saúde de Minas Gerais / Fundação Hospitalar do Estado de Minas Gerais. Belo Horizonte, MG, Brasil.
Universidade de Brasília. Faculdade de Medicina. Núcleo de Medicina Tropical. Brasília, DF, Brasil.
Governo Estadual de Minas Gerais. Secretaria Estadual de Saúde de Minas Gerais / Fundação Hospitalar do Estado de Minas Gerais. Belo Horizonte, MG, Brasil.
Universidade de Brasília. Faculdade de Medicina. Núcleo de Medicina Tropical. Brasília, DF, Brasil.
Abstract
Brazil has high rates of leprosy case detection, especially in the northern and west-central areas of the country. Effective decentralisation of routine treatment for leprosy has gathered pace since the year 2000 and this has improved access for patients, leading to a peak in new case detection in 2003 and a gradual decline thereafter. This is in parallel with specific government programmes aimed at poverty reduction. Disability prevention and surveillance for drug resistance remain important tasks within the leprosy control programme, in which six key referral centres lead the way.
Keywords
LeprosyHealth surveillance
Disease prevention
Communicable disease control
Leprosy
Communicable disease
Drug therapy
DeCS
HanseníaseVigilância em Saúde Pública
Prevenção de Doenças
Controle de Doenças Transmissíveis
Communicable Disease
Tratamento Farmacológico
Share